Skip to main content

Dr. Timothy C. Kasunic, MD

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
26
In the NPI registry since
2006
Medicare patients seen, 2024
809

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2000Medical school: Wayne State University School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    OH license 35.087790CTR · MI license 4301076035

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
809
Services billed
319,353
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, ferric carboxymaltose, 1 mg72,75067
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram37,20013
Injection, daratumumab, 10 mg and hyaluronidase-fihj13,68015
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)13,26016
Injection, pembrolizumab, 1 mg11,80013
Injection, nivolumab, 1 mg9,58011
Injection, denosumab, 1 mg7,86059
Injection, aprepitant, 1 mg7,67019
Injection, epoetin alfa, (for non-esrd use), 1000 units5,03029
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg4,95216

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 6 companies reported 6 payments worth $226 in total to this clinician.

By company
Janssen Biotech, Inc.$99.99
AstraZeneca Pharmaceuticals LP$34.24
Takeda Pharmaceuticals U.S.A., Inc.$30.89
Adc Therapeutics America, Inc.$20.79
Aveo Pharmaceuticals, Inc.$20.00
Astellas Pharma US Inc$19.94
By type
Education$120
Food and Beverage$106

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Dec 9, 2025Janssen Biotech, Inc.
Dec 9, 2025
Education
ERLEADA · Oncology · in-kind
$99.99
Feb 13, 2025Aveo Pharmaceuticals, Inc.
Feb 13, 2025
Education
FOTIVDA · Oncology · in-kind
$20.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Ohio →

Other Hematology & Oncology clinicians in Toledo

Sources

NPI registry (CMS NPPES, November 2026; record last updated December 22, 2025), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1013975903. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.